Neospark Drugs And Chemicals Private Limited. - Company Profile

It is a pharma private limited company based in Na, Telangana, India, established in 1989.
1989 Na, Telangana, India Active
Last Updated:
About Neospark Drugs And Chemicals Private Limited.

Neospark Drugs And Chemicals Private Limited., a active private limited company, was established on 29 June 1989 in Na, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24230TG1989PTC010189. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹17.10 Cr.

It upholds a compliant status. Employing 560 professional, Its leadership includes Hari Krishna Vemulapalli (Director), Gannamaneni Indrani (Director), Kalyan Kanaparti (Director). Past directors included Hari Krishna Vemulapalli, Gannamaneni Indrani, Kalyan Kanaparti. It holds ₹95.79 Cr open charges and ₹21.29 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at 241 B.L.Bagh .,Panjugutta,Hyderabad -500082, Na, Telangana.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1989PTC010189

  • Registration Number

    010189

  • Incorporation Date

    29 June 1989

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹17.10 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 17.10 Cr
  • Company Age 36 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 95.79 Cr
  • Satisfied Charges ₹ 21.29 Cr
  • Revenue Growth **** -1.81%
  • Profit Growth **** -18.22%
  • Ebitda **** -17.68%
  • Net Worth 31.99%
  • Total Assets **** 19.34%
Company report

Neospark Drugs And Chemicals Private Limited.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neospark Drugs And Chemicals Private Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neospark Drugs And Chemicals Private Limited.?
Current Directors
Name Designation Appointment Date Status
Hari Krishna Vemulapalli Director 30 Apr 2021 Current
Gannamaneni Indrani Director 18 May 2019 Current
Kalyan Kanaparti Director 18 May 2019 Current
Madhavee Latha Vemulapalli Director 18 May 2019 Current
Ankamma Rao Uyyuru Whole-Time Director 17 Aug 1994 Current
Padmaraju Lakshmana Veena Director 24 Dec 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2021 Past
Pramod Abcsdd Additional Director 21 Sep 2019 Past
Pramod Abcsdd Additional Director 21 Sep 2019 Past
Pramod Abcsdd Additional Director 21 Sep 2019 Past
Pramod Abcsdd Director 18 May 2019 Past
Pramod Abcsdd Additional Director 27 Oct 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neospark Drugs And Chemicals.

Neospark Drugs And Chemicals Private Limited., for the financial year ended 2023, experienced Minor drop in revenue, with a 1.81% decrease. The company also saw a substantial fall in profitability, with a 18.22% decrease in profit. The company's net worth Soared by an impressive increase of 31.99%.

Neospark Drugs And Chemicals revenue growth over time
Neospark Drugs And Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-1.81%
*******
*******
*******
*******
Revenue from Operations
*******
-1.72%
*******
*******
*******
*******
Total Assets
*******
19.34%
*******
*******
*******
*******
Profit or Loss
*******
-18.22%
*******
*******
*******
*******
Net Worth
*******
31.99%
*******
*******
*******
*******
EBITDA
*******
-17.68%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neospark Drugs And Chemicals?

In 2023, Neospark Drugs And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹957,900,000.00

Satisfied Charges

₹212,933,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 95.79 Cr
Latest Charge Details
Date Lender Amount Status
10 Jul 2024 State Bank Of India ₹2.90 M Open
02 Mar 1994 State Bank Of India ₹95.50 Cr Open
24 Sep 2015 Andhra Pradesh State Financial Corporation ₹8.75 Cr Satisfied
16 Nov 2010 Andhra Pradesh State Financial Corporation ₹6.00 Cr Satisfied
29 May 2009 Andhrapradesh State Financial Corporation ₹1.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Neospark Drugs And Chemicals?

Neospark Drugs And Chemicals has a workforce of 560 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neospark Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neospark Drugs And Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neospark Drugs And Chemicals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Neospark Drugs And Chemicals Private Limited. last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Simran Sharma was appointed as a Company Secretary was appointed as a Company Secretary on 30 Jun 2025 & has been associated with this company since 8 months . was completed.

  • Balance Sheet

    Progress on Neospark Drugs And Chemicals Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    A charge with State Bank Of India amounted to Rs. 0.29 Cr with Charge ID 100954535 was registered on 10 Jul 2024. was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India of Rs. 95.50 Cr registered on 02 Mar 1994 with Charge ID 90135354 was modified on 20 Nov 2023. was completed.

  • Charges

    The activity A charge registered on 24 Sep 2015 via Charge ID 10594892 with Andhra Pradesh State Financial Corporation was fully satisfied on 30 Dec 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neospark Drugs And Chemicals Private Limited.?

The CIN of Neospark Drugs And Chemicals Private Limited. is U24230TG1989PTC010189.

Where is Neospark Drugs And Chemicals Private Limited. headquartered?

Neospark Drugs And Chemicals Private Limited. is headquartered at 241 B.L.Bagh .,Panjugutta,Hyderabad -500082, Na, Telangana.

When was Neospark Drugs And Chemicals Private Limited. incorporated?

Neospark Drugs And Chemicals Private Limited. was incorporated on 29 June 1989.

Who are the current directors of Neospark Drugs And Chemicals Private Limited.?
What is the primary industry of Neospark Drugs And Chemicals Private Limited.?

The primary industry of Neospark Drugs And Chemicals Private Limited. is Manufacturing.

Is Neospark Drugs And Chemicals Private Limited. a listed company?

Neospark Drugs And Chemicals Private Limited. is unlisted.

What is the capital structure of Neospark Drugs And Chemicals Private Limited.?

The authorized capital of Neospark Drugs And Chemicals Private Limited. is ₹20.00 Cr, and the paid-up capital is ₹17.10 Cr.

What is the compliance status of Neospark Drugs And Chemicals Private Limited.?

The compliance status of Neospark Drugs And Chemicals Private Limited. is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available